Stay updated on Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision: v3.5.5 replaces v3.5.4, signaling a page update. It reflects internal maintenance rather than changes to clinical trial details presented on the page.
    Difference
    0.1%
    Check dated 2026-06-05T08:40:33.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.3 to v3.5.4, indicating a newer version of the page documentation.
    Difference
    0.1%
    Check dated 2026-05-15T04:50:59.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-23T22:09:58.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision: v3.5.2 applied, replacing v3.5.0. No user-facing content or study details were altered.
    Difference
    0.1%
    Check dated 2026-04-16T18:34:39.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The site revision label was updated from v3.4.3 to v3.5.0. No visible changes to study details or page content were observed.
    Difference
    0.1%
    Check dated 2026-03-18T20:29:13.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-11T19:01:44.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial page.